ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

OME Omega Protein Corp.

22.00
0.00 (0.00%)
17 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Omega Protein Corp. NYSE:OME NYSE Ordinary Share
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 22.00 0.00 01:00:00

Current Report Filing (8-k)

02/11/2016 8:42pm

Edgar (US Regulatory)


UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

 

 

Form 8-K

 

 

 

Current Report Pursuant to Section 13 or 15(d) of
the Securities Act of 1934

 

 

 

Date of Report (Date of earliest event reported): November 2, 2016

 

 

 

Omega Protein Corporation
(Exact name of registrant as specified in its charter)

 

 

 

Nevada
(State or other jurisdiction
of incorporation)

 

001-14003
(Commission
File Number)

76-0562134
(I.R.S. Employer
Identification No.)

 

 

2105 City West Blvd., Suite 500

Houston, Texas
(Address of principal executive offices)

77042
(Zip Code)

 

(713) 623-0060
(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

[   ]     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

[   ]     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

[   ]     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14-2(b))

 

[   ]     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CRF 240.133-4(c))

 

 
 

 

 

Item 2.02. Results of Operations and Financial Condition

 

On November 2, 2016, Omega Protein Corporation (the “Company”) issued a press release reporting the Company’s earnings for the quarter ended September 30, 2016. For additional information regarding the Company’s third quarter earnings, please refer to the Company’s press release attached to this Current Report on Form 8-K as Exhibit 99.1 and incorporated into this Item 2.02 by reference.

 

Item 9.01 Financial Statements , Pro Forma Financial Information and Exhibits

 

 

(a)

Financial Statements of business acquired.

 

None.

 

 

(b)

Pro Forma Financial Information.

 

None.

 

 

(c)

Shell Company Transactions.

 

None.

 

 

(d)

Exhibits.

 

 

99.1

Text of Press Release dated November 2, 2016 titled “ Omega Protein Announces Third Quarter 2016 Financial Results.”

 

 
 

 

   

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

Omega Protein Corporation

 

       

 

 

 

 

Dated:     November 2, 2016

 

/s/  John D. Held

 

 

 

John D. Held

 

 

 

Executive Vice President and General Counsel

 

 

1 Year Omega Protein Chart

1 Year Omega Protein Chart

1 Month Omega Protein Chart

1 Month Omega Protein Chart